Guidelines Flashcards
ATP III non-HDL-C target in patients with elevated triglycerides (>200)
non-HDL-c= VLDL + LDL-C
Goal is 30 mg/dL higher than LDL-C goal
To cover for atherogenic potential of hypertriglyceridemia
Drugs that raise HDL-C
fibrates, nicotinic acid
Fibrates help with
reducing risk of CHD in people with high triglycerides and low HDL-C
ESPECIALLY in DM patients or metabolic syndromes
Nicotinic acid helps
reduce LDL-C and risk HDL-C
Patients tend to not tolerate it due to SE (flushing)
Serum cholesterol levels correlate with
CHD risk
For every 1% reduction in LDL, equates to
1% reduction in relative risk of CHD events
If baseline levels of LDL >130 patient must be started on pharmacologic therapy AND
dietary therapy
typically need to double dose of Statin (high dose regimen)
Absolute contraindications for fibrinolytic in Cardiac event
History of CVA Cranial/Spinal surgery last 2 months BP > 180/110 Known bleeding tendencies Active bleeding last 10 days Trauma or major surgery in last 10 days Known or suspected pregnancy
Indications for fibrinolytic in Ischemic Stroke
No age limit Onset of S/S 100K Glucose > 50 No history of intracranial hemorrhage No major surgery in last 14 days No GI/urinary hemorrhage in last 21 days No head trauma/stroke in last 3 months
Exercise contraindicated in
Complete heart block
embolic conditions
decompensated CHF
uncontrolled DM
In regards to exercise Men >40 and Women >50 at risk for cardiopulmonary disorders must seek
Medical evaluation prior to working out
Need EKG before working out
Routine screenings do not include
Chest x-ray
EKG
Self-breast exams
Screenings for adults 20-39
fractionated lipid panel at 20 the q5y
Screening for adults 40-59
baseline EKG (not necessary) Colorectal screening at 50 Tonometry at 40 (IOC/glaucoma)
Screening for adults >60
stop doing prostate at 69
No recommendations for PAP >70